Authors
Hany Elsharawy, Qian He, Weizhu Zeng, Jingwen Zhou
Published in
Synthetic and systems biotechnology. Volume 16. Pages 88-98. Epub Jul 17, 2026.
Abstract
Ursolic acid (UA) is a pharmaceutically valuable pentacyclic triterpenoid, but its microbial production is constrained by inefficient cytochrome P450 catalysis and limited cofactor availability. Here, we engineered an efficient α-amyrin-producing Yarrowia lipolytica chassis for UA biosynthesis through integrated enzyme engineering, cofactor optimization, and metabolic flux balancing. Screening of heterologous plant cytochrome P450 monooxygenases identified CYP716A48 from Olea europaea as the most efficient α-amyrin oxidase in Y. lipolytica. Fusion of OeCYP716A48 with its redox partner AtCPR1 using optimized flexible linkers enhanced intramolecular electron transfer and significantly increased UA titers. The OeCYP716A48 D114Q/L211F variant enlarged the substrate-access tunnel and improved catalytic efficiency, resulting in a 5-fold increase in UA production. To support high OeCYP716A48 activity, intracellular FAD, heme, and iron availability were systematically enhanced, leading to a 14.4-fold increase in UA production. Multicopy integration of CrMAS, OeCYP716A48 D114Q/L211F, and AtCPR1 at rDNA loci further balanced pathway flux. In 5-L fed-batch fermentation, the engineered strain produced 813 ± 24 mg/L UA, representing the highest titer reported in Y. lipolytica to date. This study establishes a scalable and broadly applicable engineering strategy to overcome cytochrome P450 limitations and enable efficient triterpenoid biosynthesis in yeast.
PMID:
42502842
Bibliographic data and abstract were imported from PubMed on 26 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 3
- Comments 0